Profil

Ethgen Olivier

Département des sciences de la santé publique > Santé publique : aspects spécifiques

URSAPES

See author's contact details
Main Referenced Co-authors
Reginster, Jean-Yves  (122)
Bruyère, Olivier  (79)
Richy, Florent (39)
Hiligsmann, Mickaël  (24)
Gosset, Christiane  (14)
Main Referenced Keywords
Humans (10); osteoporosis (8); Aged (7); Female (7); Middle Aged (6);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (2)
Main Referenced Disciplines
Public health, health care sciences & services (79)
General & internal medicine (66)
Rheumatology (32)
Special economic topics (health, labor, transportation...) (23)
Endocrinology, metabolism & nutrition (12)

Publications (total 133)

The most downloaded
1344 downloads
Ethgen, O., Bruyère, O., Richy, F., Dardennes, C., & Reginster, J.-Y. (May 2004). Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature. Journal of Bone and Joint Surgery. American Volume, 86 (5), 963-974. doi:10.2106/00004623-200405000-00012 https://hdl.handle.net/2268/93240

The most cited

1451 citations (Scopus®)

Ethgen, O., Bruyère, O., Richy, F., Dardennes, C., & Reginster, J.-Y. (May 2004). Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature. Journal of Bone and Joint Surgery. American Volume, 86 (5), 963-974. doi:10.2106/00004623-200405000-00012 https://hdl.handle.net/2268/93240

Crunenberg, R., Charles, C., Buret, L., Philippe, G., Lallemand, A., & Ethgen, O. (2024). Interpretative phenomenological analysis of the collaboration among healthcare professionals in the nursing home setting. Exploratory Research in Clinical and Social Pharmacy, 100424. doi:10.1016/j.rcsop.2024.100424
Peer Reviewed verified by ORBi

Crunenberg, R., Simon Claire, & Ethgen, O. (01 October 2023). Current Practice in Weekly Pillbox Preparation and Perceived Added Value of Future Collaboration between Community Pharmacists and Home Care Nurses in Belgium. Journal of Advanced Pharmacy Research, 7 (4), 251-260. doi:10.21608/aprh.2023.222438.1228
Peer Reviewed verified by ORBi

Crunenberg, R., Philippe, G., & Ethgen, O. (25 August 2023). Preferences and perceptions of pharmacy students on the sectoral development of community pharmacy in Belgium [Paper presentation]. FIP Pharmacy Practice Research summer meeting for PhD students, postdoctoral fellows and supervisors.
Peer reviewed

Crunenberg, R., HODY, P., Ethgen, O., Hody, L., & Delille, B. (01 April 2023). Public Health Interest of Vaccination Through Community Pharmacies: A Literature Review. Journal of Advanced Pharmacy Research, 7 (2), 77-86. doi:10.21608/aprh.2023.189159.1210
Peer Reviewed verified by ORBi

Crunenberg, R., Simon, C., & Ethgen, O. (04 November 2022). Public health interest of community pharmacist and home care nurses collaboration in the realisation of weekly pillboxes: A quantitative observational cross-sectional study. Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors conference abstracts 2022. Pharmacy Education, 22 (5), 7-8. doi:10.46542/pe.2022.225.148
Peer Reviewed verified by ORBi

Crunenberg, R., Simon, C., & Ethgen, O. (04 July 2022). Public health interest of community pharmacist and home care nurses collaboration in the realization of weekly pillboxes: A quantitative observational cross-sectional study [Paper presentation]. FIP Pharmacy Practice Research Summer meeting 2022, Utrecht, Netherlands.
Editorial reviewed

Defo Tamgno, E., Tiotsa Tsapi, A., Fossi, M., Djeunang Dongho, G. B., Kah Fossah Achu, D., Ekoyol Ekobé, G., Russo, G., Ethgen, O., & Sanou Sobze, M. (12 March 2021). Malaria in West Cameroon: An Assessment of the Populations’ Knowledge, Attitudes and Practices. Central African Journal of Public Health, 7 (2), 47-52. doi:10.11648/j.cajph.20210702.11
Peer reviewed

Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019). The health economics burden of sarcopenia: a systematic review. Maturitas, 119, 61-9. doi:10.1016/j.maturitas.2018.11.003
Peer Reviewed verified by ORBi

Renault, V., Hambe, H. A., Van Vlaenderen, G., Timmermans, E., Mohamed, A. M., Ethgen, O., & Saegerman, C. (2019). Economic impact of contagious caprine pleuropneumonia and cost-benefit analysis of the vaccination programmes based on a one-year continuous monitoring of flocks in the arid and semi-arid lands of Kenya. Transboundary and Emerging Diseases. doi:10.1111/tbed.13317
Peer Reviewed verified by ORBi

Ethgen, O., Makhija, D., Harenski, K., Combes, A., Mekontso Dessap, A., MORIMONT, P., & Quintel, M. (2018). Cost-Effectivness of ECCO2R in the management of acute respiratory distress syndrome (ARDS). Critical Care Medicine.
Peer Reviewed verified by ORBi

Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J.-Y. (March 2017). The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcified Tissue International, 100 (3), 229-234. doi:10.1007/s00223-016-0220-9
Peer Reviewed verified by ORBi

Ethgen, O., & Bruyère, O. (2017). Epidemiological product assessment. In G. Emilien, R. Weitkunat, ... F. Lüdicke (Eds.), Consumer Perception of Product Risks and Benefits (pp. 85-104). Springer International Publishing. doi:10.1007/978-3-319-50530-5_5
Peer reviewed

Ethgen, O., Tchoconte, C., Beaudart, C., Buckinx, F., Reginster, J.-Y., & Bruyère, O. (April 2016). The future prevalence of sarcopenia in Europe. Osteoporosis International, 27 (Supplement 1), 53-54.
Peer Reviewed verified by ORBi

Cooper, C., Bardin, T., Brandi, M. L., Cacoub, P., Caminis, J., Civitelli, R., Cutolo, M., Dere, W., Devogelaer, J. P., Diez-Perez, A., Einhorn, T. A., Emonts, P., Ethgen, O., Kanis, J. A., Kaufman, J. M., Kvien, T. K., Lems, W. F., McCloskey, E., Miossec, P., ... Reginster, J.-Y. (February 2016). Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Aging Clinical and Experimental Research, 28 (1), 1-16. doi:10.1007/s40520-015-0522-1
Peer Reviewed verified by ORBi

Ethgen, O., Hiligsmann, M., Burlet, N., & Reginster, J.-Y. (January 2016). Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures. Osteoporosis International, 27, 301-308. doi:10.1007/s00198-015-3319-3
Peer Reviewed verified by ORBi

Ethgen, O., Hiligsmann, M., Burlet, N., & Reginster, J.-Y. (2015). Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures. Archives of Public Health. doi:10.1186/s13690-015-0099-3
Peer Reviewed verified by ORBi

Ethgen, O., Hiligsmann, M., Bruyère, O., & Reginster, J.-Y. (2015). Cost-effectiveness of dairy products supplemented with vitamin D in the prevention of osteoporotic fractures. Osteoporosis International, 26 (S1), 372-S373.
Peer Reviewed verified by ORBi

Bruyère, O., Reginster, J.-Y., & Ethgen, O. (2015). La médecine personnalisée : aspects pharmacoéconomiques. Revue Médicale de Liège, 70 (5-6), 339-342.
Peer reviewed

Delbecque, L., Desseilles, M., Taquet, M., Ethgen, O., & Chassany, O. (January 2014). When Collecting Patient Data Gets Electronic: The Upsurge of Ehealth and The Importance of Big Data to Shape Modern Health Care. ISPOR Connections, 20 (1), 5-8.
Peer reviewed

Slomian, J., Appelboom, G., Ethgen, O., Reginster, J.-Y., & Bruyère, O. (2014). Can new information and communication technologies help in the management of osteoporosis ? Women's Health, 10 (3), 229-232. doi:10.2217/whe.14.15
Peer Reviewed verified by ORBi

Slomian, J., Reginster, J.-Y., Ethgen, O., Appelboom, G., & Bruyère, O. (2014). Opportunity and challenges of eHealth and mHealth for patients and caregivers. Austin Journal of Public Health and Epidemiology, 1 (2), 3-5.
Peer reviewed

Ethgen, O., De Lemos Esteves, F., Bruyère, O., & REGINSTER, J.-Y. (2013). What do we know about the safety of corticosteroids in rheumatoid arthritis? Current Medical Research and Opinion, 29 (9), 1147-60. doi:10.1185/03007995.2013.818531
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Neuprez, A., Zegels, B., Gillet, P., HUSKIN, J.-P., & Reginster, J.-Y. (2012). Health-related quality of life after total knee or hip replacement for osteoarthritis: a 7-year prospective study. Archives of Orthopaedic and Trauma Surgery. doi:10.1007/s00402-012-1583-7
Peer Reviewed verified by ORBi

Miossec, P., Verweij, C. L., Klareskog, L., Pitzalis, C., Barton, A., Lekkerkerker, F., Reiter, S., Laslop, A., Breedveld, F., Abadie, E., Flamion, B., Dere, W., Mpofu, S., Goel, N., Ethgen, O., Mitlak, B., Ormarsdottir, S., RAO, R. F., Tsouderos, Y., & Reginster, J.-Y. (2011). Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies. Annals of the Rheumatic Diseases, 70 (10), 1713-8. doi:10.1136/ard.2011.154252
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Neuprez, A., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (November 2010). Etude de la qualité de vie après la mise en place d’une prothèse de hanche ou de genou pour cause d’arthrose : une étude de cohorte avec un suivi de 7 ans. Revue du Rhumatisme, 77 (Suppl.3), 141.
Peer Reviewed verified by ORBi

Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (June 2010). Health-related quality of life after total knee or hip replacement: a 7-year prospective study. Annals of the Rheumatic Diseases, 69 (Suppl.3), 469.
Peer Reviewed verified by ORBi

Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (May 2010). Health-related quality of life after total knee or hip replacement : a 7-year prospective study. Osteoporosis International, 21 (Suppl.1), 26.
Peer Reviewed verified by ORBi

Hiligsmann, M., Rabenda, V., Gathon, H.-J., Ethgen, O., & Reginster, J.-Y. (2010). Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications. Calcified Tissue International, 86, 202-210. doi:10.1007/s00223-009-9329-4
Peer Reviewed verified by ORBi

Hiligsmann, M., Gathon, H.-J., Bruyère, O., Ethgen, O., Rabenda, V., & Reginster, J.-Y. (2010). Cost-Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence. Value in Health, 13 (4), 394-401. doi:10.1111/j.1524-4733.2009.00687.x
Peer Reviewed verified by ORBi

Hiligsmann, M., Rabenda, V., Gathon, H.-J., Ethgen, O., & Reginster, J.-Y. (March 2009). Clinical en economic implications of non-adherence with osteoporosis medications. Osteoporosis International, 20 (S1), 16.
Peer Reviewed verified by ORBi

Hiligsmann, M., Ethgen, O., Bruyère, O., Richy, F., Gathon, H.-J., & Reginster, J.-Y. (2009). Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis. Value in Health, 12 (5), 687-696. doi:10.1111/j.1524-4733.2008.00497.x
Peer Reviewed verified by ORBi

Ethgen, O., Hiligsmann, M., & Reginster, J.-Y. (2009). Modelling the uptake and diffusion of innovative technology: a critical and strategic feature of budget impact analysis and risk-sharing agreements. In Value in Health (pp. 12, A395).
Peer reviewed

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2008). Cost-utility of calcium and vitamin D supplementation in the treatment of postmenopausal osteoporotic women. Osteoporosis International, 19 (S2), 363.
Peer Reviewed verified by ORBi

Hiligsmann, M., Rabenda, V., Gathon, H.-J., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (December 2008). Impact of medication non-compliance and non-persistence on pharmacoeconomic evaluations in osteoporosis. Osteoporosis International, 19 (S2), 282.
Peer Reviewed verified by ORBi

Hiligsmann, M., Rabenda, V., Gathon, H.-J., Ethgen, O., & Reginster, J.-Y. (November 2008). Impact of medication non-compliance and non-persistence on pharmacoeconomic evaluations in osteoporosis. Value in Health, 11 (6), 542. doi:10.1016/S1098-3015(10)66788-5
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (July 2008). Efficiency of calcium and vitamin D in the management of osteoporosis [Paper presentation]. 7th European Conference on Health Economics, Rome, Italy.

Hiligsmann, M., Bruyère, O., Ethgen, O., Pire, G., Gathon, H.-J., & Reginster, J.-Y. (July 2008). Efficiency and recommendations for osteoporosis screening strategy [Paper presentation]. 7th European Conference on Health Economics, Rome, Italy.

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Efficiency of calcium and vitamin D supplementation in the management of osteoporosis. Osteoporosis International, 19 (S1), 113.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Cost-effectiveness of mass screening and targeted biphosphonates treatment in osteoporosis. Osteoporosis International, 19 (S1), 117.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., Pire, G., & Reginster, J.-Y. (April 2008). Efficiency and recommendations for osteoporosis screening strategy. Osteoporosis International, 19 (S1), 116.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (April 2008). Cost-utility of strontium ranelate in the treatment of postmenopausal women. Osteoporosis International, 19 (S1), 6.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., Gathon, H.-J., & Reginster, J.-Y. (2008). Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women. BONE, 43 (6), 991-4. doi:10.1016/j.bone.2008.08.119
Peer Reviewed verified by ORBi

Hiligsmann, M., Ethgen, O., Richy, F., & Reginster, J.-Y. (2008). Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcified Tissue International, 82 (4), 288-92. doi:10.1007/s00223-008-9117-6
Peer Reviewed verified by ORBi

Hiligsmann, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (2008). An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification of Patients with Osteoporosis. Disease Management and Health Outcomes, 16 (6), 429-438. doi:10.2165/0115677-200816060-00008
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2007). Efficience d'un dépistage de masse de l'ostéoporose par ultrasons: approche économique par microsimulation. Revue du Rhumatisme, 74 (10-11), 1072-3.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (December 2007). Analyse coût-efficacité d'un dépistage de masse de l'ostéoporose par DEXA combiné à un traitement par alendronate chez la femme ostéoporotique. Revue du Rhumatisme, 74 (10-11), 1072-3.
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (October 2007). Cost-effectiveness of bone densitometry screening combined with alendronate therapy for those who have osteoporosis. Value in Health, 10 (6), 236. doi:10.1016/S1098-3015(10)64899-1
Peer Reviewed verified by ORBi

Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (October 2007). Cost-effectiveness of osteoporosis screening campaign for Belgian women. Value in Health, 10 (6), 395. doi:10.1016/S1098-3015(10)65384-3
Peer Reviewed verified by ORBi

Hiligsmann, M., Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (March 2007). Rationale and development of an individual patient-based model to accurately assess the efficacy of osteoporosis management. Osteoporosis International, 18 (S1), 169.
Peer Reviewed verified by ORBi

Neuprez, A., Hiligsmann, M., Bruyère, O., Ethgen, O., & Reginster, J.-Y. (2007). Prevention of hip fractures in osteoporosis. Minerva Ortopedica e Traumatologica, 58 (5), 423-437.
Peer reviewed

Rabenda, V., Burlet, N., Ethgen, O., Raeman, F., Belaiche, J., & Reginster, J.-Y. (May 2005). A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal antiinflammatory drugs. Annals of the Rheumatic Diseases, 64 (5), 688-693. doi:10.1136/ard.2004.026658
Peer Reviewed verified by ORBi

Richy, F., Schacht, E., Bruyère, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y. (March 2005). Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis. Calcified Tissue International, 76 (3), 176-186. doi:10.1007/s00223-004-0005-4
Peer Reviewed verified by ORBi

Ethgen, O., Richy, F., Cools, P., Devillers, J., & Reginster, J.-Y. (March 2005). Health-related quality of life as a predictor of direct costs in osteoarthritis. Osteoporosis International, 16 (Suppl.3), 59.
Peer Reviewed verified by ORBi

Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (March 2005). Screening for osteoporosis: systematic DXA or pre-screening with questionnaires? An economic point of view. Osteoporosis International, 16 (Suppl.3), 101.
Peer Reviewed verified by ORBi

Richy, F., Schacht, E., Bruyère, O., Ethgen, O., Gourlay, M., & Reginster, J.-Y. (March 2005). An indirect comparison of the efficacies of vitamin D and its hydroxylated analogs in postmenopausal and corticosteroid-induced osteoporosis. Osteoporosis International, 16 (Suppl.3), 29.
Peer Reviewed verified by ORBi

Ethgen, O., Gosset, C., De Maeseneer, J., & Reginster, J.-Y. (March 2005). Physical functionning is the most severely affected health-related quality of life dimension during the aging process. Osteoporosis International, 16 (Suppl.3), 25-26.
Peer Reviewed verified by ORBi

Ethgen, O., GILLAIN, D., Gillet, P., Gosset, C., Jousten, A., & Reginster, J.-Y. (March 2005). Age- and sex-stratified prevalence of physical disabilities and handicap in the general population. Osteoporosis International, 16 (Suppl.3), 25.
Peer Reviewed verified by ORBi

Rabenda, V., Burlet, N., Ethgen, O., Raeman, F., BELAICHE, J., & Reginster, J.-Y. (March 2005). A naturalistic study of the determinants of healthrelated quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs. Osteoporosis International, 16 (Suppl.3), 100-101.
Peer Reviewed verified by ORBi

Bruyère, O., Wuidart, M. A., Di Palma, E., Gourlay, M., Ethgen, O., Richy, F., & Reginster, J.-Y. (February 2005). Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Archives of Physical Medicine and Rehabilitation, 86 (2), 303-307. doi:10.1016/j.apmr.2004.05.019
Peer Reviewed verified by ORBi

Richy, F., Ethgen, O., Bruyère, O., Mawet, A., & Reginster, J.-Y. (December 2004). Primary prevention of osteoporosis: Mass screening scenario or prescreening with questionnaires? An economic perspective. Journal of Bone and Mineral Research, 19 (12), 1955-1960. doi:10.1359/JBMR.040903
Peer Reviewed verified by ORBi

Richy, F., Deceulaer, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2004). Development and validation of the ORACLE score to predict risk of osteoporosis. Mayo Clinic Proceedings, 79 (11), 1402-1408. doi:10.4065/79.11.1402
Peer Reviewed verified by ORBi

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Bouvenot, G., Audran, M., Herrero-Beaumont, G., Moore, A., Eliakim, R., Haim, M., & Reginster, J.-Y. (July 2004). Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach [letter to the editor]. Annals of the Rheumatic Diseases, 63 (7), 759-766. doi:10.1136/ard.2003.015925
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ross, P., Sen, S. S., Radican, L., Deceulaer, F., Ben Sedrine, W., Ethgen, O., & Reginster, J.-Y. (May 2004). Risk assessment tools for osteoporosis: scope and limits. Osteoporosis International, 15 (Suppl.1), 11.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (May 2004). Do patients with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 15 (Suppl.1), 50.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (May 2004). BMD in men: which normative data? Osteoporosis International, 15 (Suppl.1), 54.
Peer Reviewed verified by ORBi

Ethgen, O., Bruyère, O., Richy, F., Dardennes, C., & Reginster, J.-Y. (May 2004). Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature. Journal of Bone and Joint Surgery. American Volume, 86 (5), 963-974. doi:10.2106/00004623-200405000-00012
Peer Reviewed verified by ORBi

Richy, F., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (April 2004). Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporosis International, 15 (4), 301-310. doi:10.1007/s00198-003-1570-5
Peer Reviewed verified by ORBi

Ethgen, O., Vanparijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (March 2004). Social support and health-related quality of life in hip and knee osteoarthritis. Quality of Life Research, 13 (2), 321-330. doi:10.1023/B:QURE.0000018492.40262.d1
Peer Reviewed verified by ORBi

Ben Sedrine, W., Ethgen, O., Devogelaer, J.-P., Depresseux, G., Kaufman, J.-M., Goemaere, S., & Reginster, J.-Y. (2004). Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening? Aging Clinical and Experimental Research, 16 (5), 413-419. doi:10.1007/bf03324573
Peer Reviewed verified by ORBi

Richy, F., Ethgen, O., Bruyère, O., deceulaer, F., & Reginster, J.-Y. (2004). From sample size to effect-size : small study effect investigation (SSEi). Internet Journal of Epidemiology, 1 (2).
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ross, P. D., Sen, S. S., Radican, L., De Ceulaer, F., Ben Sedrine, W., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (January 2004). Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. QJM: Monthly Journal of the Association of Physicians, 97 (1), 39-46. doi:10.1093/qjmed/hch002
Peer Reviewed verified by ORBi

Ethgen, O., & Reginster, J.-Y. (January 2004). Degenerative musculoskeletal disease. Annals of the Rheumatic Diseases, 63 (1), 1-3. doi:10.1136/ard.2003.009613
Peer Reviewed verified by ORBi

Ethgen, O., Gillain, D., Gillet, P., Gosset, C., Jousten, A., & Reginster, J.-Y. (2004). Age- and sex-stratified prevalence of physical disabilities and handicap in the general population. Aging Clinical and Experimental Research, 16 (5), 389-97. doi:10.1007/BF03324569
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Lejeune, E., Kvasz, A., Zegels, B., & Reginster, J.-Y. (November 2003). Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC index. Journal of Rheumatology, 30 (11), 2452-2459.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). BMD in men: which normative data? Osteoporosis International, 14 (Suppl. 7), 66-67.
Peer Reviewed verified by ORBi

Rabenda, V., Ethgen, O., Belaiche, J., Raeman, F., Haim, M., & Reginster, J.-Y. (November 2003). Impact of osteoarthritis and chronic back pain on health-related quality of life among patients on NSAIDS. Osteoporosis International, 14 (Suppl. 7), 89-90.
Peer Reviewed verified by ORBi

Richy, F., Pire, G., Maassen, P., Ethgen, O., Gourlay, M., Bruyère, O., & Reginster, J.-Y. (November 2003). Evaluation of an osteoporosis screening campaign in the general population: does misclassification by screening test impact on the perception of the campaign? Osteoporosis International, 14 (Suppl. 7), 68.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Jacques, J., Bruyère, O., Richy, F., & Reginster, J.-Y. (November 2003). Do patient with osteoporotic hip fracture recover their initial health-related quality of life? Osteoporosis International, 14 (Suppl. 7), 66.
Peer Reviewed verified by ORBi

Ethgen, O., Rabenda, V., Bruyère, O., & Reginster, J.-Y. (November 2003). Projecting the prevalence of osteoarthritis and osteoporosis over the five forthcoming decades: their increasing impact on public health. Osteoporosis International, 14 (Suppl. 7), 65-66.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Rational to use OSIRIS® (osteoporosis index of risk) to prescreen for osteoporosis in the general population. Osteoporosis International, 14 (Suppl. 7), 67-68.
Peer Reviewed verified by ORBi

Ethgen, O., Gosset, C., Richy, F., & Reginster, J.-Y. (November 2003). Physical function is the most severely impaired health-related quality of life dimension during the aging process. Osteoporosis International, 14 (Suppl. 7), 65.
Peer Reviewed verified by ORBi

Bruyère, O., Wuidart, M. A., di Palma, E., Gourlay, M., Ethgen, O., Richy, F., & Reginster, J.-Y. (November 2003). Controlled whole body vibration to decrease fall risk and improve health related quality of life in elderly patients. Osteoporosis International, 14 (Suppl. 7), 63.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Brugneaux, C., Richy, F., Bruyère, O., & Reginster, J.-Y. (November 2003). Prospective evaluation of health-related quality of life in total hip and knee arthroplasties. Osteoporosis International, 14 (Suppl. 7), 66.
Peer Reviewed verified by ORBi

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Deceulaer, F., Bonvenot, G., Audran, M., Herrero-Beaumont Cuenca, G., Moore, A., Eliakim, R., Van De Putte, L., Haim, M., & Reginster, J.-Y. (November 2003). Time-dependent assessment of the gastrointestinal risk induced by low-dose aspirin intake: a meta-analysis. Osteoporosis International, 14 (Suppl. 7), 95.
Peer Reviewed verified by ORBi

Richy, F., Bruyère, O., Ethgen, O., Rabenda, V., Bouvenot, G., Audran, M., Herrero Beaumont Cuenca, G., Moore, A., Eliakim, R., Van De Putte, L., Haim, M., & Reginster, J.-Y. (November 2003). Time-dependent risk of gastrointestinal complications induced by NSAIDS use: a consensus statement using meta-analytic approach. Osteoporosis International, 14 (Suppl. 7), 9.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ross, P. D., Sen, S. S., Radican, L., De Ceulaer, F., Ben Sedrine, W., Ethgen, O., & Reginster, J.-Y. (November 2003). Risk assessment tools for osteoporosis: scope and limits. Osteoporosis International, 14 (Suppl. 7), 68-69.
Peer Reviewed verified by ORBi

Combescure, C., Daures, J. P., Chevallier, T., Ethgen, O., Richy, F., Viethel, P., & Reginster, J.-Y. (November 2003). Economic evaluation of OSIRIS® (osteoporosis index of risk), a prescreening tool for prediction of osteoporosis risk, using decision trees and Markov models. Osteoporosis International, 14 (Suppl. 7), 88.
Peer Reviewed verified by ORBi

Richy, F., Pire, G., Maassen, P., Gourlay, M., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Evaluation of a campaign for osteoporosis screening in the general population: what is the follow-up given by general practitioners to a positive screening result? Osteoporosis International, 14 (Suppl. 7), 67.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Neuprez, A., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2003). Bone mineral density and vertebral fractures in women who have discontinued hormone replacement therapy: a retrospective population-based study. Osteoporosis International, 14 (Suppl. 7), 67.
Peer Reviewed verified by ORBi

Richy, F., Gourlay, M., Ross, P. D., Sen, S. S., Radican, L., Ethgen, O., & Reginster, J.-Y. (September 2003). Risk assessment tools for osteoporosis: Scope and limits. Arthritis and Rheumatism, 48 (number 9 (suppl.)), 215.
Peer Reviewed verified by ORBi

Richy, F. Y., Bruyère, O., Ethgen, O., Cucherat, M., & Reginster, J.-Y. (September 2003). Structural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthritis: a comprehensive meta-analysis. Arthritis and Rheumatism, 48 (number 9 (suppl.)), 214.
Peer Reviewed verified by ORBi

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (14 July 2003). Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - A comprehensive meta-analysis. Archives of Internal Medicine, 163 (13), 1514-1522. doi:10.1001/archinte.163.13.1514
Peer Reviewed verified by ORBi

Ethgen, O., Tellier, V., Sedrine, W. B., De Maeseneer, J., Gosset, C., & Reginster, J.-Y. (June 2003). Health-related quality of life and cost of ambulatory care in osteoporosis: how may such outcome measures be valuable information to health decision makers and payers? BONE, 32 (6), 718-724. doi:10.1016/S8756-3282(03)00089-9
Peer Reviewed verified by ORBi

Bruyère, O., COLLETTE, J., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (May 2003). Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. Journal of Rheumatology, 30 (5), 1043-50.
Peer Reviewed verified by ORBi

Bruyère, O., Dardenne, C.-B., Lejeune, E., Zegels, B., Pahaut, A., Richy, F., Seidel, L., Ethgen, O., Henrotin, Y., & Reginster, J.-Y. (May 2003). Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis. BONE, 32 (5), 541-545. doi:10.1016/S8756-3282(03)00059-0
Peer Reviewed verified by ORBi

Ethgen, O., Gillain, D., Gillet, P., Gosset, C., Jousten, A., & Reginster, J.-Y. (2003). Etude relative à la mise en œuvre de mécanismes d’aides en faveur des personnes en perte d’autonomie, Rapport final. https://orbi.uliege.be/handle/2268/57406

Bruyère, O., Honore, A., Ethgen, O., Rovati, L. C., Giacovelli, G., Henrotin, Y., Seidel, L., & Reginster, J.-Y. (January 2003). Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis and Cartilage, 11 (1), 1-5. doi:10.1053/joca.2002.0848
Peer Reviewed verified by ORBi

Ethgen, O., Richy, F., Gosset, C., Hanssens, L., & Reginster, J.-Y. (2003). Prevention de la vulnerabilite de la personne agee: un defi demographique. Revue Médicale de Liège, 58 (4), 175-82.
Peer reviewed

Ethgen, O., Gosset, C., Richy, F., & Reginster, J.-Y. (2003). Physical function is the most severely impaired health-related quality of life dimension during the aging process [Paper presentation]. Fourth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, Nice, France.

Ethgen, O., Bruyère, O., Richy, F., Paul, I., Gosset, C., & Reginster, J.-Y. (November 2002). Burden of chronic osteoarticular disorders compared to others commonly reported chronic conditions. Results from a large health interview survey of Belgian individuals aged over 45 years. Osteoporosis International, 13 (Suppl.3), 49-50.
Peer Reviewed verified by ORBi

Richy, F., Bousquet, J., Devogelaer, J.-P., Ehrlich, G., Meunier, P. J., Peel, N., Morii, H., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (November 2002). Inhaled corticosteroids effects on bone in asthmatic and COPD patients: what is the evidence? Osteoporosis International, 13 (Suppl.3), 22.
Peer Reviewed verified by ORBi

Ethgen, O., Bruyère, O., Tancredi, A., Richy, F., De Ceulaer, F., & Reginster, J.-Y. (November 2002). Patient health profiles in osteoarthritis: is there a difference according to follow-up pattern? Results from the Belgian National Health Interview Survey. Osteoporosis International, 13 (Suppl.3), 49.
Peer Reviewed verified by ORBi

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Osteoporosis International, 13 (Suppl.3), 51.
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L. C., & Reginster, J.-Y. (November 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Osteoporosis International, 13 (Suppl.3), 51.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Lejeune, E., Zegels, B., Kvasz, A., & Reginster, J.-Y. (November 2002). A comparative analysis between the time trade-off and the willingness to pay approaches in hip and knee osteoarthritis. Osteoporosis International, 13 (Suppl. 3), 47.
Peer Reviewed verified by ORBi

Ethgen, O., & Reginster, J.-Y. (November 2002). L'evaluation de la qualite de vie dans les essais therapeutiques: un pas vers une approche holistique de la sante. Revue Médicale de Liège, 57 (11), 695-700.
Peer reviewed

Bruyère, O., Collette, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (November 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three-year prospective study. Osteoporosis International, 13 (Suppl.3), 51.
Peer Reviewed verified by ORBi

Richy, F., Bruyère, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (November 2002). Structural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthrits: a comprehensive meta-analysis. Osteoporosis International, 13 (Suppl.3), 55-56.
Peer Reviewed verified by ORBi

Ethgen, O., Richy, F., De Ceulaer, F., Bruyère, O., & Reginster, J.-Y. (November 2002). Musculoskeletal disorders in a time demographic changes: a real challenge for the future in Europe and Northern America. Osteoporosis International, 13 (Suppl.3), 48-49.
Peer Reviewed verified by ORBi

Ethgen, O., Tancredi, A., Lejeune, E., Zegels, B., Kvazs, A., & Reginster, J.-Y. (September 2002). Do willingness to pay and time trade-off approaches suitably reflect health outcomes in hip and knee osteoarthritis? Arthritis and Rheumatism, 46 (number 9 (suppl.)), 73.
Peer Reviewed verified by ORBi

Bruyère, O., COLLETTE, J., Lejeune, E., Ethgen, O., Richy, F., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three year prospective study. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 152-3.
Peer Reviewed verified by ORBi

Bruyère, O., COLLETTE, J., Lejeune, E., Richy, F., Ethgen, O., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (September 2002). Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progression. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 149.
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Lejeune, E., Giacovelli, G., Richy, F., Seidel, L., Henrotin, Y., Rovati, L., & Reginster, J.-Y. (September 2002). Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomes. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 153.
Peer Reviewed verified by ORBi

Ethgen, O., Bruyère, O., Richy, F., Paul, I., Gosset, C., & Reginster, J.-Y. (September 2002). Health and economic burden of chronic osteoarticular disorders in the population aged over 45 years: a comparative analysis with other commonly reported chronic health dysfunctions. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 469.
Peer Reviewed verified by ORBi

Richy, F., Bousquet, J., Devogelaer, J.-P., Ehrlich, G., Meunier, P., Peel, N., Morii, H., Ethgen, O., Bruyère, O., & Reginster, J.-Y. (September 2002). Meta-analysis of the effects of inhaled corticosteroids on bone in asthmatic and COPD patients. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 464.
Peer Reviewed verified by ORBi

Ethgen, O., Kahler, K. H., Kong, S. X., REGINSTER, J.-Y., & Wolfe, F. (2002). The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. Journal of Rheumatology, 29 (6), 1147-55.
Peer Reviewed verified by ORBi

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Osteoarthritis and Cartilage, 9 (Suppl.B), 19-20.
Peer Reviewed verified by ORBi

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Arthritis and Rheumatism, 44 (Suppl.1), 183.
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Rovati, L. C., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Clinical Rheumatology, 5 (Suppl.1), 412.
Peer Reviewed verified by ORBi

Ethgen, O., Van Parijs, P., Delhalle, S., Rosant, S., Bruyère, O., & Reginster, J.-Y. (2001). Importance of social companionship in the determination of health-related quality of life in hip and knee osteoarthrits. Clinical Rheumatology, 5 (Suppl.1), 413.
Peer Reviewed verified by ORBi

Ben Sedrine, W., Ethgen, O., Devogelaer, J., Kaufman, J., Goemaere, S., Depresseux, G., & Reginster, J.-Y. (2001). Toward an efficient strategy for osteoporosis screening : diagnostic accuracy and cost effectiveness of the proposals of the Belgian social security institute. Arthritis and Rheumatism, 44 (1598), 319.
Peer Reviewed verified by ORBi

Ethgen, O., Tellier, V., Ben Sedrine, W., De Maeseneer, J., Gosset, C., & Reginster, J.-Y. (2001). Health-related quality of life and cost of ambulatory care in osteoporosis. How may such outcome measures be valuable information to health decision markers and payers ? Clinical Rheumatology, 20, 427.
Peer Reviewed verified by ORBi

Ben Sedrine, W., Ethgen, O., Devogelaer, J., Depresseux, G., Kaufman, J., Goemaere, S., & Reginster, J.-Y. (2001). Evaluation of the proposals of the Belgian social security institute for the reimbursement of bone densitometry, toward a cost effective strategy for osteoporosis screening. Clinical Rheumatology, 20, 421.
Peer Reviewed verified by ORBi

Bruyère, O., Ethgen, O., Rovati, L. C., Giacovelli, G., Seidel, L., Henrotin, Y., & Reginster, J.-Y. (2001). Radiographic severity of knee osteoarthrits is highly correlated with future progression of the disease. Osteoarthritis and Cartilage, 9 (Suppl.B), 44-45.
Peer Reviewed verified by ORBi

Ethgen, O., Tellier, C., Ben Sedrine, W., De Maeseneer, J., Gosset, C., & Reginster, J.-Y. (2000). Health-related quality of life and cost of ambulatory care in osteoporosis. May such outcome measures be valuable information to health decision makers and payers ? [Paper presentation]. Second International Meeting on Social and Economic Aspects of Osteroporosis and Bone Diseases, Liège, Belgium.

Reginster, J.-Y., Ethgen, O., & Dang Vu, T. (2000). La chondroprotection aujourd’hui. Rhumatologie, 52 (8), 13-16.
Peer Reviewed verified by ORBi

Ben Sedrine, W., Goemaere, S., Depresseux, G., Ethgen, O., Devogelaer, J., Kaufman, J., & Reginster, J.-Y. (2000). Validation of the critera proposed by the Belgian social security institute for reimbursement of bone mineral density : a study in a sample of 4727 ambulatory subjects. Arthritis and Rheumatism, 43 (S1), 453.
Peer Reviewed verified by ORBi

Ethgen, O., Khaler, K., Kong, S., Reginster, J.-Y., & Wolfe, F. (2000). Are health-related quality of life scores useful in predicting the use of the health care services ? Exploration in patients with osteoarthritis. Arthritis and Rheumatism, 43 (S1), 582.
Peer Reviewed verified by ORBi

Ethgen, O., Kahler, K., Kong, S., Reginster, J.-Y., & Wolfe, F. (2000). Health-related quality of life scores and future use of health care resources in patients with rheumatoid arthritis and osteoarthritis : implication for health services research in arthritis. Annals of the Rheumatic Diseases, 59 (S1), 277.
Peer Reviewed verified by ORBi

Ben Sedrine, W., Goemaere, S., Depresseux, G., Ethgen, O., Devogelaer, J., Kaufman, J., & Reginster, J.-Y. (2000). The simple calculates osteoporosis risk estimation (score) tool is more useful to reduce densitometry costs than for selecting patient with high risk of osteoporosis. Arthritis and Rheumatism, 43 (S1), 809.
Peer Reviewed verified by ORBi

Ethgen, O., Tellier, V., Ben Sedrine, W., De Maeseneer, J., Gosset, C., & Reginster, J.-Y. (2000). Health-related quality of life and cost of ambulatory care in osteopororis . May such outcome measures be valuable information to health decision makers and payers ? Osteoporosis International, 11 (S5), 5-S6.
Peer Reviewed verified by ORBi

Reginster, J.-Y., Gillet, P., Ben Sedrine, W., Brands, G., Ethgen, O., de Froidmont, C., & Gosset, C. (1999). Direct costs of hip fractures in patients over 60 years of age in Belgium. PharmacoEconomics, 15 (5), 507-514. doi:10.2165/00019053-199915050-00008
Peer Reviewed verified by ORBi

Ethgen, O., Ethgen, D., Guillemin, F., & Reginster, J.-Y. (1997). Comparative analysis of healthcare use in patients with rheumatoid arthritis and control subjects without chronic disease. Calcified Tissue International, 61, 510.
Peer Reviewed verified by ORBi

Contact ORBi